Novel expression vectors and uses thereof
CA 2446260 C · Owner: Tahtinen, Marja · Inventors: Blazevic, Vesna; Toots, Urve; Krohn, Kai
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel vectors to DNA vaccines and gene , therapeutics containing said vectors to methods for the preparation of the vectors and DNA vaccines and gene therapeutics containing the vectors and to , therapeutic uses of said vectors. More specifically the present invention , relates to novel vectors comprising (a) an expression cassette of a gene of a nuclear-anchoring protein, which contains (i) a DNA binding domain capable of binding to a specific DNA sequence and (ii) a functional domain capable of binding to a nuclear component and (b) a multimerized DNA sequence forming a binding site for the anchoring protein and optionally (c) one or more , expression …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 3, 2002 and granted June 14, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.